Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,120 | N/A | N/A |
| Depreciation Amortization | 160 | N/A | N/A |
| Other Working Capital | 1,440 | N/A | N/A |
| Other Operating Activity | -4,690 | 0 | 0 |
| Operating Cash Flow | $-19,210 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,470 | N/A | N/A |
| Other Investing Activity | -160 | 0 | 0 |
| Investing Cash Flow | $-1,630 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 159,360 | 0 | 0 |
| Financing Cash Flow | $159,360 | $N/A | $N/A |
| Exchange Rate Effect | 138,500 | N/A | N/A |
| Beginning Cash Position | 5,480 | N/A | N/A |
| End Cash Position | 149,860 | N/A | N/A |
| Net Cash Flow | $144,370 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -19,210 | N/A | N/A |
| Free Cash Flow | -19,210 | 0 | 0 |